Lichao Sun

Dr. Lichao Sun


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Biotechnology Advances
Verified
Journal Article
Closed access
LSLichao Sun
Lichao Sun
FXFengjiao Xin
Fengjiao Xin
HAHal Alper
Hal Alper

5 August 2023 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
YLYing Liu
Ying Liu
LSLichao Sun
Lichao Sun
YHYi-Xin Huo
Yi-Xin Huo
SGShuyuan Guo
Shuyuan Guo
Vanillin (4-hydroxy-3-methoxybenzaldehyde) is one of the most popular flavors with wide applications in food, fragrance, and pharmaceutical industries. However, the high cost and limited yield of plant extraction failed to meet the vast market demand of natural vanillin. Vanillin biotechnology has emerged as a sustainable and cost-effective alternative to supply vanillin. In this review, we explored recent advances in vanillin biosynthesis and highlighted the potential of vanillin biotechnology. In particular, we addressed key challenges in using microorganisms and provided promising approaches for improving vanillin production with a special focus on chassis development, pathway construction and process optimization. Future directions of vanillin biosynthesis using inexpensive precursors are also thoroughly discussed.

1 December 2020 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
LSLichao Sun
Lichao Sun
HAHal Alper
Hal Alper

Verified
Journal Article
Open access
PDF file
YXYingying Xie
Yingying Xie
SLShuying Li
Shuying Li
LSLei Sun
Lei Sun
SLShujun Liu
Shujun Liu
FWFengzhong Wang
Fengzhong Wang
FXFengjiao Xin
Fengjiao Xin
Lung cancer is a common disease that is associated with poor prognosis. Fungal immunomodulatory protein from Nectria haematococca (FIP-nha) has potential as a lung cancer therapeutic; as such, illuminating its anti-tumor mechanism is expected to facilitate novel treatment options. Here, we showed that FIP-nha affects lung adenocarcinoma growth ex vivo and in vivo. Comparative quantitative proteomics showed that FIP-nha negatively regulates PI3K/Akt signaling and induces cell cycle arrest, autophagy, and apoptosis. We further demonstrated that FIP-nha suppresses Akt phosphorylation, leading to upregulation of p21 and p27 and downregulation of cyclin B1, cyclin D1, CDK2, and CDK4 expression, ultimately resulting in G1/S and G2/M cell cycle arrest. Meanwhile, FIP-nha-induced PI3K/Akt downregulation promotes A549 apoptosis by increasing the expression ratio of Bax/Bcl-2 and c-PARP and autophagy by decreasing the phosphorylation of mTOR. Thus, we comprehensively revealed the anti-tumor mechanism of FIP-nha, which inhibits tumor growth by modulating PI3K/Akt-regulated cell cycle arrest, autophagy, and apoptosis, and provided the basis for further application of fungal immunomodulatory proteins, especially FIP-nha.

27 December 2017 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
XLXin Liu
Xin Liu
TLTengfei Liu
Tengfei Liu
YZYuebin Zhang
Yuebin Zhang
FXFengjiao Xin
Fengjiao Xin
SMShuofu Mi
Shuofu Mi
LSLichao Sun
Lichao Sun

29 August 2024 in ACS Synthetic Biology
Verified
Journal Article
Closed access
PDPengyu Dong
Pengyu Dong
YFYunjuan Fan
Yunjuan Fan
YHYi-Xin Huo
Yi-Xin Huo
LSLichao Sun
Lichao Sun
SGShuyuan Guo
Shuyuan Guo